Second international congress on immunopharmacology : delivery systems and current strategies for drug design

Acevedo, Reinaldo and Landys, Mario and Acosta, Armando and Bercovier, Herve and Norazmi, Mohd Nor and Ferro, Valerie and Sarmiento, Maria Elena (2013) Second international congress on immunopharmacology : delivery systems and current strategies for drug design. BMC Immunology, 14 (Supple). S1. ISSN 1471-2172 (https://doi.org/10.1186/1471-2172-14-S1-S1)

[thumbnail of Acevedo-etal-BMCI-2013-Second-international-congress-on-immunopharmacology]
Preview
Text. Filename: Acevedo_etal_BMCI_2013_Second_international_congress_on_immunopharmacology.pdf
Final Published Version
License: Creative Commons Attribution 2.5 logo

Download (232kB)| Preview

Abstract

The 2nd International Congress on Immunopharmacology was held in June of 2011 at the Conference Center of Plaza America in Varadero, Cuba. The main goal of this meeting was to provide state-of-the-art communications for scientists, manufacturers, regulators and healthcare workers, to accelerate progress in the development of biological and biotechnological products and to promote exchange/scientific cooperation between researchers. 300 delegates from 22 countries attended the conference. The wide-ranging programme commenced with a plenary session and then split into a series of parallel workshops and symposia, covering “Advances in Immunopharmacology”, “Neuroimmunology”, “Therapeutic Biological Products”, “Prophylaxis and Treatment of Helicobacter pylori”, “Pharmacology of Cytochrome P450”, “Hereditary Ataxias” and “Delivery Systems and Current Strategies for Drug Design”. In this last Symposium, a substantial body of data was presented relating to the development of delivery systems with adjuvant and vaccine potential and also to strategies focused in therapeutic and prophylactic approaches against tuberculosis. This issue is dedicated to some of the results presented in this area.